Jacobs Levy Equity Management, Inc Agenus Inc Transaction History

Jacobs Levy Equity Management, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $365,734 - $784,328	-142,865 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.69 - $5.25 $19,168 - $37,411	-7,126 Reduced 4.75%	142,865 $389,000
Q4 2020 Feb 16, 2021	BUY	$3.17 - $4.49 $138,681 - $196,428	43,748 Added 41.18%	149,991 $477,000
Q3 2020 Nov 16, 2020	SELL	$2.98 - $5.2 $33,420 - $58,318	-11,215 Reduced 9.55%	106,243 $425,000
Q2 2020 Aug 17, 2020	SELL	$2.29 - $4.24 $645 - $1,195	-282 Reduced 0.24%	117,458 $462,000
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $2,021 - $4,622	-1,053 Reduced 0.89%	117,740 $288,000
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $286,291 - $522,689	118,793 New	118,793 $483,000
Q4 2018 Feb 14, 2019	SELL	$1.59 - $2.66 $100,170 - $167,580	-63,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $7,959 - $12,114	-5,006 Reduced 7.36%	63,000 $135,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $129,511 - $266,472	57,306 Added 535.57%	68,006 $154,000
Q1 2018 May 15, 2018	SELL	$3.51 - $6.04 $869,040 - $1.5 Million	-247,590 Reduced 95.86%	10,700 $50,000
Q4 2017 Feb 13, 2018	BUY	$3.26 - $4.78 $300,246 - $440,238	92,100 Added 55.42%	258,290 $842,000
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $490,993 - $626,439	141,090 Added 562.11%	166,190 $733,000
Q2 2017 Nov 09, 2017	BUY	N/A	25,100	25,100 $98,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.